ABT Abbott Laboratories
Health Care · S&P 500
Next earnings: Thu 28 Jan 2027 · estimated
What 31 analyst firms say about Abbott Laboratories: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
32 rated views · 34 analyst/firm records · 31 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8067
- S&P 500 · Safest consensus · 6MGood · #17 in the index85
Recent analyst activity · last 90 days
Our tracked history has 26 reports on ABT from 18 analyst firms in the last 90 days (31 firms in the past year).
Comparing each firm's latest target with its previous one: 4 raised their price target, 8 lowered it, 3 left it unchanged and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: Wells Fargo raised its target from $119.00 (set 22 Oct 2026) to $120.00 on 23 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David A Toung | Hold | 27 Oct 2026 | 125.00 USD |
| Argus | David Round | Hold | 27 Oct 2026 | — |
| Baird | David Rescott | Buy | 22 Oct 2026 | 123.00 USD |
| Bank of America Securities | Unnamed analyst | — | 12 Jun 2026 | 102.00 USD |
| Barclays | Christopher Pasquale | Buy | 7 Oct 2026 | 120.00 USD |
| Barclays | Matt Miksic | Buy | 7 Oct 2026 | 120.00 USD |
| Benchmark | Bruce D. Jackson | Buy | 17 Apr 2026 | 120.00 USD |
| Bernstein | Lee Hambright | Buy | 22 Oct 2026 | 120.00 USD |
| BTIG | Marie Thibault | Buy | 22 Oct 2026 | 125.00 USD |
| Citigroup | Joanne Wuensch | Buy | 22 Oct 2026 | 122.00 USD |
| Daiwa | Narumi Nakagiri | Hold | 23 Jul 2026 | 103.00 USD |
| Erste Group | Hans Engel | Hold | 25 Jun 2026 | — |
| Evercore ISI | Vijay Kumar | Buy | 5 Oct 2026 | 124.00 USD |
| Freedom Capital | Unnamed analyst | Buy | 29 Jan 2026 | — |
| Freedom Capital Markets | Ilya Zubkov | Buy | 20 Jul 2026 | 125.00 USD |
| Goldman Sachs | David Roman | Buy | 27 May 2026 | 113.00 USD |
| Jefferies | Matthew C Taylor | Buy | 22 Oct 2026 | 130.00 USD |
| JPMorgan | Robbie Marcus | Buy | 22 Oct 2026 | 118.00 USD |
| Leerink Partners | Michael Kratky | Hold | 22 Oct 2026 | 106.00 USD |
| Mizuho | Anthony Petrone | Hold | 17 Apr 2026 | 115.00 USD |
| Oppenheimer | Suraj Kalia | Buy | 17 Apr 2026 | 115.00 USD |
| Piper Sandler | Adam C Maeder | Buy | 21 Oct 2026 | 118.00 USD |
| Raymond James | Jayson T Bedford | Buy | 21 Oct 2026 | 115.00 USD |
| RBC Capital Markets | Kendall Au | Buy | 22 Oct 2026 | 125.00 USD |
| RBC Capital Markets | Shagun Singh | Buy | 17 Jul 2026 | 130.00 USD |
| Redburn | Ed Ridley-Day | Buy | 2 Oct 2026 | 127.00 USD |
| Stifel | Rick Wise | Buy | 17 Apr 2026 | 120.00 USD |
| TD Cowen | Joshua Jennings | Buy | 22 Oct 2026 | 118.00 USD |
| UBS | Patrick Wood | Buy | 28 Jul 2026 | 125.00 USD |
| Weiss Ratings | Unnamed analyst | — | 18 Sep 2026 | — |
| Wells Fargo | Larry Biegelsen | Buy | 22 Oct 2026 | 119.00 USD |
| William Blair | Unnamed analyst | Buy | 20 Nov 2025 | — |
| Wolfe Research | Mike Polark | Buy | 13 Aug 2026 | Conflicting reports · excluded |
| Data feed RESEARCH | Research Team | Hold | 1 May 2026 | 110.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 08:15 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.